Pura Vida Investments’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Pura Vida Investments’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-322,452	Closed	-$1.52M	–	238
2020 Q3	$1.52M	Buy	322,452 +311,352	+2,805%	+$1.58M	0.08%	124
2020 Q2	$68K	Buy	+11,100	New	+$45.7K	0.01%	120
2017 Q2	–	Sell	-8,982	Closed	-$325K	–	103
2017 Q1	$325K	Sell	8,982 -5,168	-37%	-$228K	0.1%	74
2016 Q4	$709K	Sell	14,150 -850	-6%	-$44.7K	0.26%	57
2016 Q3	$787K	Buy	15,000 +1,750	+13%	+$83.6K	0.24%	74
2016 Q2	$548K	Hold	13,250	–	–	0.23%	65
2016 Q1	$538K	Sell	13,250 -250	-2%	-$8.59K	0.24%	68
2015 Q4	$560K	Buy	+13,500	New	+$453K	0.24%	65

Other funds holding FPRX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pura Vida Investments's FPRX Position: Q4 2020 in Review

Pura Vida Investments sold out of Five Prime Therapeutics, Inc. (FPRX) in Q4 2020, closing a stake of 322,452 shares — an estimated $1.52M sold.

Pura Vida Investments first reported a position in FPRX in Q4 2015 and held it in 8 quarters. The position peaked at $1.52M in Q3 2020. 125 funds tracked by Wall St. Rank hold FPRX as of Q4 2020.

Pura Vida Investments reported no remaining Five Prime Therapeutics, Inc. position as of Q4 2020 after selling out during the quarter.
Pura Vida Investments sold 322,452 Five Prime Therapeutics, Inc. shares in Q4 2020, an estimated $1.52M.
Pura Vida Investments first reported a position in Five Prime Therapeutics, Inc. in Q4 2015 and held it in 8 quarters.
Pura Vida Investments's Five Prime Therapeutics, Inc. position peaked at $1.52M in Q3 2020.
125 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q4 2020.

Based on Pura Vida Investments's 13F filing for Q4 2020, filed 16 Feb 2021.